AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04885348 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control Group (Dental Home Education Leaflets)
Description: Only Dental Home Education Leaflets were provided every six months for 2 years.
Study NCT01955577 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin D3 cholecalciferol
Study NCT00816322 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Omega-3 fatty acids
Description: EPA 2.1 g/d+DHA 1.1 g/d
Study NCT02380183 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Civco Needle Guidance Device
Description: Needle guidance device will be used while nerve block is performed.
Study NCT02638688 — intervention group
Intervention type: OTHER
Intervention: ultrasound
Study NCT03362541 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MS INFoRm
Description: MS INFoRm incorporates principles of self-management and adult learning theory. The contents address the sources of fatigue, ways of monitoring fatigue, and strategies to reduce fatigue.
Study NCT03362541 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care Control Group
Description: The usual care webpage will contain content from widely available resources about MS fatigue.
Study NCT03147196 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bicalutamide
Description: Given PO
Study NCT03147196 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT03147196 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT00816322 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: high oleic oil
Study NCT02094313 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Description: The aim of this pilot study is to evaluate the efficacy and the safety of a decrease of cholesterol blood levels, induced by taking atorvastatin, on sperm quality of normocholesterolaemic and healthy men without confounding factors.
Study NCT03147196 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Raloxifene Hydrochloride
Description: Given PO
Study NCT02297009 — intervention group
Intervention type: PROCEDURE
Intervention: Buccal swab
Description: Buccal swabs will be taken from the volunteers
Study NCT02623959 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaires
Description: Symptom and quality of life questionnaires completed at baseline and at 10 - 14 days after receiving Saline or Doxycycline.
Study NCT02623959 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Symptom and quality of life questionnaires completed at baseline and at 10 - 14 days after receiving Saline or Doxycycline.
Study NCT02623959 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl Patch
Description: Participant given a Fentanyl patch, 12 mcg/hour, which should be worn at follow up visit 5 days after IPC placement.
Study NCT02623959 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl Patch
Description: Participant given a Fentanyl patch, 12 mcg/hour, which should be worn at follow up visit 5 days after IPC placement.
Study NCT01124370 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: remedē (TM) system
Description: Implantation of the remedē (TM) system, including implantable pulse generator, stimulation lead, and (optional) sensing lead. Nightly provision of unilateral transvenous phrenic nerve therapy during sleep periods.
Study NCT04063605 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Pilates
Description: This exercise model focus on the awareness of the neutral position of the spine and strengthen the deep postural muscles of the spine. Training of trunk muscles is emphasized and trunk stabilization is achieved and more difficult activities are initiated and thus, body awareness is improved. There are general principles to be followed during exercises. These; The principle of concentration is respiration, central focus, control, stability and isolation. These principles are achieved by simultaneous muscle activation of muscles responsible for trunk stabilization (multifidus, diaphragm, transversus abdominis and pelvic floor muscles). In order for an exercise to become a clinical pilates exercise, trunk stabilization must be ensured and breath control should be established in each exercise.
Study NCT04063605 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Classic Physiotherapy
Description: This exercise program will include strengthening, stretching, posture exercises, balance and gait exercises. Aim is to improve muscle strength and prevent shortness of muscles. Also, balance and gait exercise aim to improve walking capacity.
Study NCT00807105 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: H-coil dTMS
Description: treatment with deep TMS stimulation.
Study NCT02926924 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Wound Vac
Description: a therapeutic technique using a vacuum dressing to promote healing in acute or chronic wounds and enhance healing of first and second degree burns.
Study NCT02926924 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Dressing
Description: standard dressing with drain tube and bandage
Study NCT04742062 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ApTOLL
Description: ApTOLL is a Toll-like receptor 4 (TLR4) antagonist, a receptor that is involved in innate immune responses but also responds to tissue damage, and therefore it is directly involved in a large number of diseases where the inflammatoryy response is involved. ApTOLL has demonstrated specific binding to human TLR4 as well as a TLR4 antagonistic effect, reducing inflammation and improving outcome after different disease models.
Study NCT04742062 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 100 mL 0.9% Sodium Chloride solution
Study NCT00848510 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: EMD 525797
Description: Abituzumab will be administered as an intravenous infusion for an hour at a dose of 250 milligram (mg) to 1500 mg at Weeks 1, 3 and 5. In case of clinical benefit (stable disease \[SD\], complete response \[CR\], or partial response \[PR\]) that will be assessed by the Response Evaluation Criteria in Solid Tumors (RECIST Version 1.0) during initial 6 Weeks, subjects will be allowed to continue treatment at the start of Week 7 at the given dose (250 mg or 500 mg or 1000 mg or 1500 mg) every second week until intolerance to treatment, withdrawal of consent, or the subject is no longer benefiting from treatment in the opinion of the Investigator.
Study NCT01399762 — intervention group
Intervention type: DEVICE
Intervention: mechanical recanalization
Description: Endovascular thrombus extraction by mechanical recanalization devices
Study NCT03378037 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: 20 minutes of acupuncture treatment, twice a week for 2 weeks. Acupoints will be manually stimulated every 10 minutes.
Study NCT03378037 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Acupuncture
Description: 20 minutes of acupuncture treatment, twice a week for 2 weeks. Acupoints will be manually stimulated every 10 minutes.
Study NCT02034019 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Study NCT02034019 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Punctum Plug
Study NCT02034019 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Punctum Plug
Study NCT04632043 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Endotracheal intubation
Description: Endotracheal intubation
Study NCT01275768 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Endoscopic radio-frequency ablation
Description: Endobiliary radiofrequency catheter is 8Fr in diameter and can easily be passed over a 0.035 guide wire through the biopsy channel of a duodenoscope at the time of endoscopic retrograde cholangiography (ERC). Its use in the biliary system was heralded by animal experiments following which power settings of 7-10 Watts for 2 minutes were found to provide adequate ablation. The ablation results in charring of the tumor and this is expected to enhance the patency of SEMS
Study NCT01275768 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic radio-frequency ablation
Description: Endobiliary radiofrequency catheter is 8Fr in diameter and can easily be passed over a 0.035 guide wire through the biopsy channel of a duodenoscope at the time of endoscopic retrograde cholangiography (ERC). Its use in the biliary system was heralded by animal experiments following which power settings of 7-10 Watts for 2 minutes were found to provide adequate ablation. The ablation results in charring of the tumor and this is expected to enhance the patency of SEMS
Study NCT05267795 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimentally-induced pain
Description: Specific pain levels were applied on the participants' fingernails in each of 40 experimental trials using pressure algometry.
Study NCT01270828 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pregabalin
Description: Tablets, 82.5 to 660mg, once per day. Duration: 19 weeks
Study NCT01270828 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Placebo, 82.5 to 660mg, once per day. Duration: 13 weeks
Study NCT02429908 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: TM-Ardis Interbody
Description: The TM Ardis implant is a single device manufactured wholly from Trabecular Metal™ (porous tantalum) material, a highly porous, three-dimensional biomaterial designed for biologic fixation. is indicated for use with autogenous bone graft as an intervertebral body fusion device at one or two contiguous levels in the lumbosacral region (L2- S1) in the treatment of degenerative disc disease (DDD) with up to Grade 1 spondylolisthesis or retrolisthesis at the involved level(s).
Study NCT04292470 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Description: Amitriptyline tablet
Study NCT01435707 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: epidural steroid injection with Triamcinolone 40mg
Description: epidural steroid injection with Triamcinolone 40mg
Study NCT01435707 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Selective transforaminal epidural block with triamcinolone 20 mg
Description: Selective transforaminal epidural block with triamcinolone 20 mg
Study NCT01435707 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: caudal epidural steroid injection with Triamcinolone 20mg
Description: caudal epidural steroid injection with Triamcinolone 20mg
Study NCT01435707 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Selective transforaminal epidural block with triamcinolone 40 mg
Description: Selective transforaminal epidural block with triamcinolone 40 mg
Study NCT04248907 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 0 pound tension
Description: A digital fish scale will be attached to the distal strap of a gel liner to measure the distraction values while casting. A digital fish scale can measure in pounds or kilograms depending on how you set it. The digital fish scale will be held in place while casting to maintain a consistent tension between the scale and the residual limb.
Study NCT04248907 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 2 pound tension
Description: A digital fish scale will be attached to the distal strap of a gel liner to measure the distraction values while casting. A digital fish scale can measure in pounds or kilograms depending on how you set it. The digital fish scale will be held in place while casting to maintain a consistent tension between the scale and the residual limb.
Study NCT04248907 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 4 pound tension
Description: A digital fish scale will be attached to the distal strap of a gel liner to measure the distraction values while casting. A digital fish scale can measure in pounds or kilograms depending on how you set it. The digital fish scale will be held in place while casting to maintain a consistent tension between the scale and the residual limb.
Study NCT00517049 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PRO95780
Description: Intravenous repeating dose
Study NCT00517049 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rituximab
Description: Intravenous repeating dose
Study NCT01954433 — intervention group
Intervention type: PROCEDURE
Intervention: Operated TSA Patients
Description: Total shoulder prosthesis: Anatomic or reverse total shoulder replacement is a well-standardized procedure usually performed under general anesthesia with the patient in a beach-chair position
Study NCT01954433 — intervention group
Intervention type: PROCEDURE
Intervention: Operated RCR Patients
Description: Arthroscopic rotator cuff tear reconstruction. The shoulder arthroscopy is performed according to internal and international standard procedure with patients positioned in beach-chair position under general anesthesia.
Study NCT01954433 — intervention group
Intervention type: PROCEDURE
Intervention: Resection interposition suspension arthroplasty (RISA)
Description: One of five surgical techniques can be used in this study, as routinely performed by each surgeon:~1. RISA with FCR-Ligament (flexor carpi radialis ligament) modified according to Epping~2. RISA with FCR-Ligament modified according to Weilby~3. RISA with APL-Ligament (abductor pollicis longus ligament)~4. RISA with Graftjacket modified according to Weilby~5. Resection arthroplasty
Study NCT04546802 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Elbasvir / Grazoprevir Oral Tablet
Description: Elbasvir / Grazoprevir
Study NCT03135106 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erdafitinib
Description: A single 4-mg of erdafitinib tablet will be administered on Day 1 in Treatment A and on Day 5 in Treatment B and C.
Study NCT03135106 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluconazole
Description: A 400-mg fluconazole orally (4\*100 mg capsules) will be administered from Day 1 to Day 11.
Study NCT03135106 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: A 200-mg itraconazole orally (2\*100 mg capsules) will be administered from Day 1 to Day 11.
Study NCT01114451 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Removal of surgical skin staples
Description: Skin staples will be removed using standard technique with subsequent placement of steri-trips
Study NCT01165177 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Herpes Zoster Vaccine GSK1437173A
Description: Intramuscular injection
Study NCT01165177 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intramuscular injection
Study NCT02162498 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Feeding buddies
Description: The Window of Opportunity program is implementing feeding buddies within their comprehensive programming. Their feeding buddies intervention targets all mothers at ANC for promoting health behaviors, especially exclusive breastfeeding.~The NIH study is an implementation science award to evaluate the feeding buddies intervention, specifically among HIV positive recipients and evaluating the outcome of adherence to PMTCT recommendations.
Study NCT00781937 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: liraglutide
Description: Liraglutide 3.0 mg per day administered in a 6.0 mg/mL, 3 mL FlexPen® for subcutaneous (under the skin) injection, once daily
Study NCT00781937 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Liraglutide placebo 3 mL FlexPen® for subcutaneous (under the skin) injection, once daily
Study NCT00216047 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTK787
Description: PTK787 daily
Study NCT00216047 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: Trastuzumab 4 mg/kg IV week 1, followed by 2 mg/kg weekly with disease evaluation every other cycle\*
Study NCT01263249 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Catheter Anterior to the Femoral Nerve
Description: Extremity randomized to Anterior Placement will be given a peripheral nerve block with the catheter placed just anterior to the femoral nerve. 4cc of Ropivicaine will be administered continuously every hour by a pain pain pump and the outcome measures will be tested.
Study NCT01263249 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Catheter Posterior to the Femoral Nerve
Description: Extremity randomized to Posterior Placement will be given a peripheral nerve block with the catheter placed just posterior to the femoral nerve. 4cc of Ropivicaine will be administered continuously every hour by a pain pain pump and the outcome measures will be tested.
Study NCT00013611 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Proleukin
Description: Recombinant IL-2 was given at a dose of 4.5 MIU twice daily subcutaneously for 5 consecutive days every 8 weeks, in addition to antiretroviral therapy, for 6 cycles. After the first 6 cycles, additional cycles were given to either achieve or maintain the patient's CD4+ cell count goal.
Study NCT01150045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: celecoxib
Description: Patients receive celecoxib 400 mg administered by mouth, once daily.
Study NCT01150045 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-fluorouracil
Description: Patients receive 400 mg/m\^2 intravenous bolus then 2400 mg/m\^2 continuous intravenous infusion over 46-48 hours.
Study NCT01150045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil
Description: Patients receive 400 mg/m\^2 intravenous bolus then 2400 mg/m\^2 continuous intravenous infusion over 46-48 hours.
Study NCT01150045 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: placebo
Description: Patients receive placebo administered by mouth, once daily.
Study NCT01150045 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: oxaliplatin
Description: Patients receive 85 mg/m\^2 intravenous over two hours.
Study NCT01150045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: oxaliplatin
Description: Patients receive 85 mg/m\^2 intravenous over two hours.
Study NCT01150045 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: leucovorin
Description: Patients receive 400 mg/m\^2 intravenous over two hours.
Study NCT01150045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: leucovorin
Description: Patients receive 400 mg/m\^2 intravenous over two hours.
Study NCT03194867 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Isatuximab SAR650984
Description: Pharmaceutical form: solution for infusion~Route of administration: intravenous
Study NCT01438385 — intervention group
Intervention type: PROCEDURE
Intervention: Interventional Endoscopy
Description: Advanced imaging endoscopic or therapeutic endoscopy
Study NCT00939237 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ateronon
Description: 7 mg lycopene dietary supplement supplied as one Ateronon capsule taken daily
Study NCT00939237 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT03489902 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transobturator Paravaginal Repair
Description: Transobturator application of sutures to the white line in cases needing paravaginal repair
Study NCT03489902 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: traditional transvaginal Paravaginal Repair
Description: traditional transvaginal application of sutures to the white line
Study NCT02547701 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: P-3058
Study NCT03472001 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reflection and feedback
Description: 2-hour training involving 10 written clinical cases to encourage students to practice thinking like a dermatologist in their clinical reasoning, and to help students build adequate illness scripts of skin diseases
Study NCT03194867 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isatuximab SAR650984
Description: Pharmaceutical form: solution for infusion~Route of administration: intravenous
Study NCT03194867 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab REGN2810
Description: Pharmaceutical form: solution for infusion~Route of administration: intravenous
Study NCT00543062 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Inhaled placebo
Description: Inhaled Staccato placebo (0 mg)
Study NCT00543062 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Oral placebo
Description: Oral placebo (identical to 400 mg moxifloxacin)
Study NCT00543062 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Inhaled prochlorperazine 5 mg
Description: Staccato prochlorperazine 5 mg, single dose
Study NCT00543062 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Inhaled prochlorperazine 10 mg
Description: Inhaled prochlorperazine 10 mg, single dose
Study NCT00543062 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Oral moxifloxacin
Description: Oral moxifloxacin 400 mg, si/ngle dose
Study NCT00464945 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 13-valent Pneumococcal Conjugate Vaccine
Description: 1 dose at 2,3,4 and 12 months of age
Study NCT00464945 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: 13-valent Pneumococcal Conjugate Vaccine
Description: 1 dose at 2,3,4 and 12 months of age